Cheshire, United Kingdom

Andrew John Williams




Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Macclesfield, GB (2014)
  • Cheshire, GB (2015 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Andrew John Williams: Pioneering Innovations in Pharmaceuticals

Introduction

Andrew John Williams, an accomplished inventor from Cheshire, GB, has made significant contributions to the field of pharmaceuticals. With three patents to his name, Williams is recognized for his innovative work that paves the way for advancements in medical treatments.

Latest Patents

Among his latest patents is a unique compound characterized as a pyrimidine sulfonamide, which can be further processed into pharmaceutically acceptable salts. This compound exhibits properties beneficial for the treatment of diseases and conditions where modulation of chemokine receptor activity provides therapeutic advantages. The patent includes details on crystalline forms, processes for obtaining the compound, and pharmaceutical compositions containing this novel drug entity.

Career Highlights

Andrew John Williams has dedicated his career to enhancing pharmaceutical innovations at AstraZeneca AB. His expertise in chemical compounds and their therapeutic applications has positioned him as a leading figure in the research and development of new medications.

Collaborations

Throughout his career, Williams has collaborated with esteemed colleagues including Stephen Connolly and Mark Richard Ebden. These partnerships have been instrumental in successfully advancing his research efforts, driving forward the development of new pharmaceutical solutions.

Conclusion

Andrew John Williams continues to be a pivotal player in the pharmaceutical industry, with his recent patents underscoring his commitment to innovation and medical advancement. His work not only exemplifies individual brilliance but also contributes significantly to the collective efforts of his esteemed colleagues at AstraZeneca AB.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…